Drug Pricing Suit Not Subject To Medicare Process, Appellants Tell 5th Circuit
SAN ANTONIO — The government holds a “constitutionally dubious” position in a challenge to the Medicare drug price negotiation law, and a federal judge erred in dismissing on the grounds that...To view the full article, register now.
Already a subscriber? Click here to view full article